Effect of Alpha-2 Agonists on the Locomotor Activity in Adult Zebrafish


98 / 48

Authors

  • Saranya, R Department of Veterinary Pathology, Madras Veterinary College, Chennai
  • Ramasamy, T Department of Veterinary Pharmacology and Toxicology, Madras Veterinary College, Chennai
  • Ramesh, S 2Department of Veterinary Pharmacology and Toxicology, Madras Veterinary College, Chennai
  • Srinivasan. M.R Veterinary Clinical Complex, Veterinary College and Research Institute, Tirunelveli, TANUVAS

https://doi.org/10.62757/IVA.2024.101.10.36-42

Keywords:

Alpha-2 agonists, Kinovea software, locomotor activity, zebra fish

Abstract

This study aimed to validate zebrafish as a suitable model for investigating the sedative impact of alpha-2 adrenergic receptor agonists. Zebrafish were exposed to xylazine (500 and 1000 µg/L), clonidine (50 and 500 µg/L), and dexmedetomidine (5 and 50 µg/L), and their locomotor activity was recorded using a Sony 13.6MP digital camera at 5-minute intervals up to 45 min post-exposure. Kinovea software was used to track and analyze the distance travelled and the swimming speed. Xylazine exhibited decreased locomotor activity at 500 µg/L but increased activity at 1000 µg/L, possibly indicating overlapping effects on α-1 receptor adrenergic receptors. Clonidine showed no significant reduction, possibly because of its lower affinity to the zebrafish α-2 receptor compared to the humanα-2 receptor, or could have lower absorption through the skin and gills due to the low logP value of clonidine. Dexmedetomidine significantly decreased the locomotor activity due to its 10 times higher α-2 adrenergic receptor selectivity as compared to xylazine and clonidine. These findings support the use of adult zebrafish as an alternative model to explore the effects of α-2 receptor agonists in drug discovery research.

Downloads

Download data is not yet available.

References

Gertler, R., Brown, H. C., Mitchell, D. H., and Silvius, E. N. (2001). Dexmedetomidine: A novel sedative-analgesic agent. Proceedings (Baylor University. Medical Center), 14(1) : 13–21.

Hunter, J. C., Fontana, D. J., Hedley, L. R., Jasper, J. R., Lewis, R., Link, R. E., Secchi, R., Sutton, J., and Eglen, R. M. (1997). Assessment of the role of α2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. British Journal of Pharmacology, 122(7) : 1339–1344. https://doi.org/10.1038/sj.bjp.0701520

Lemke, K. A. (2004). Perioperative use of selective alpha-2 agonists and antagonists in small animals. The Canadian Veterinary Journal, 45(6) : 475–480.

Li, F., Lin, J., Liu, X., Li, W., Ding, Y., Zhang, Y., Zhou, S., Guo, N., and Li, Q. (2018). Characterization of the locomotor activities of zebrafish larvae under the influence of various neuroactive drugs. Annals of Translational Medicine, 6(10) : 173–173. https://doi.org/10.21037/atm.2018.04.25

Long, K., Kostman, S. J., Fernandez, C., Burnett, J. C., and Huryn, D. M. (2019). Do Zebrafish Obey Lipinski Rules? ACS Medicinal Chemistry Letters, 10(6) : 1002–1006. https://doi.org/10.1021/acsmedchemlett.9b00063

Morikane, D., Zang, L., and Nishimura, N. (2020). Evaluation of the Percutaneous Absorption of Drug Molecules in Zebrafish. Molecules, 25(17) : 3974. https://doi.org/10.3390/molecules25173974

Pankaj Gupta, Shailaja B Khobragade, Vyas M Shingatgeri, and Srinivisan M Rajaram. (2014). Assessment of locomotion behavior in adult Zebrafish after acute exposure to different pharmacological reference compounds. Drug Development and Therapeutics, 5(2) : 127–133.

Rosa, J. G. S., Lima, C., and Lopes-Ferreira, M. (2022). Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review. International Journal of Molecular Sciences, 23(12) : 6647. https://doi.org/10.3390/ijms23126647

Ruuskanen, J. O., Laurila, J., Xhaard, H., Rantanen, V.-V., Vuoriluoto, K., Wurster, S., Marjamäki, A., Vainio, M., Johnson, M. S., and Scheinin, M. (2005). Conserved structural, pharmacological and functional properties among the three human and five zebrafish α2-adrenoceptors. British Journal of Pharmacology, 144(2) : 165–177. https://doi.org/10.1038/sj.bjp.0706057

Selvaraj, V., Venkatasubramanian, H., Ilango, K., and Santhakumar, K. (2019a). A simple method to study motor and non-motor behaviors in adult zebrafish. Journal of Neuroscience Methods, 320 : 16–25. https://doi.org/10.1016/j.jneumeth.2019.03.008

Selvaraj, V., Venkatasubramanian, H., Ilango, K., and Santhakumar, K. (2019b). A simple method to study motor and non-motor behaviors in adult zebrafish. Journal of Neuroscience Methods, 320 : 16–25. https://doi.org/10.1016/j.jneumeth.2019.03.008

Sysoev, Y. I., Meshalkina, D. A., Petrov, D. V., Okovityi, S. V., Musienko, P. E., and Kalueff, A. V. (2019). Pharmacological screening of a new alpha-2 adrenergic receptor agonist, mafedine, in zebrafish. Neuroscience Letters, 701 : 234–239. https://doi.org/10.1016/j.neulet.2019.03.001

Virtanen, R., Savola, J.-M., Saano, V., and Nyman, L. (1988). Characterization of the selectivity, specificity and potency of medetomidine as an a2-adrenoceptor agonist. 150 : 9–14.

Submitted

2024-10-22

Published

2024-10-22

How to Cite

Saranya, R, Ramasamy, T, Ramesh, S, & Srinivasan. M.R. (2024). Effect of Alpha-2 Agonists on the Locomotor Activity in Adult Zebrafish. The Indian Veterinary Journal, 101(10), 36-42. https://doi.org/10.62757/IVA.2024.101.10.36-42